|Bid||8.00 x 900|
|Ask||8.20 x 1400|
|Day's range||7.66 - 8.10|
|52-week range||7.34 - 58.37|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||10 Aug 2021 - 16 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||16.00|
SAN DIEGO, July 28, 2021--The suit alleges defendants issued false statements re Frequency Therapeutics business & prospects, resulting in its stock trading at inflated prices.
NEW YORK, July 20, 2021--INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Reminds Investors of a Securities Class Action Against Frequency, Inc. (NASDAQ: FREQ) and Deadline
NEW YORK, July 16, 2021--The law firm of Kirby McInerney LLP announces that a securities class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ: FREQ) securities from November 16, 2020 through March 22, 2021, inclusive (the "Class Period"). Investors have until August 2, 2021 to apply to the Court to be appointed as lead plaintiff in the lawsuit.